{"eventGroups":[{"description":"Patients receive bendamustine hydrochloride IV over 30-60 minutes on days 1 and 2, etoposide IV over 60-240 minutes on days 1-3, dexamethasone PO on days 1-4, and filgrastim SC beginning on day 5 and continuing until peripheral blood stem cell collection is complete. Patients undergo leukapheresis daily for a minimum of 3 days or until \\> 5 x 10\\^6 CD34+/kg has been collected.\n\n.\n\nbendamustine hydrochloride: Given IV\n\ndexamethasone: Given PO\n\nfilgrastim: Given SC\n\nleukapheresis: Given IV\n\nlaboratory biomarker analysis: Correlative studies\n\nflow cytometry: Correlative studies\n\netoposide: Given IV","id":"EG000","otherNumAffected":34,"otherNumAtRisk":34,"seriousNumAffected":6,"seriousNumAtRisk":34,"title":"Treatment (Chemotherapy and Colony-stimulating Factor)"}],"frequencyThreshold":"5","otherEvents":[{"organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":34,"numAtRisk":34}],"term":"Lymphopenia"},{"organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":31,"numAtRisk":34}],"term":"Thrombocytopenia"},{"organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":33,"numAtRisk":34}],"term":"Neutropenia"},{"organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":34}],"term":"Leukopenia"},{"organSystem":"Metabolism and nutrition disorders","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":34}],"term":"Hypophosphatemia"},{"organSystem":"Metabolism and nutrition disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":34}],"term":"Hyperglycemia"},{"organSystem":"Musculoskeletal and connective tissue disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":34}],"term":"Muscle weakness"},{"organSystem":"Vascular disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":34}],"term":"Hypotension"}],"seriousEvents":[{"organSystem":"Vascular disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":34}],"term":"Hypotension"},{"organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":34}],"term":"Stroke"},{"organSystem":"Renal and urinary disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":34}],"term":"Renal insufficiency"},{"organSystem":"Cardiac disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":34}],"term":"Atrial fibrillation"},{"organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":34}],"term":"Neutropenic fever"},{"organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":34}],"term":"Sepsis"}]}